PTCH1 and chronic myelogenous leukemia, BCR-ABL1 positive: Our data demonstrated that Ptch1 and Ptch2 were significantly increased in murine LTHSC (Fig. 1A) and there was a trend for increased PTCH1 in CML LSC (data not shown), however this did not predict imatinib failure.